Tumor angiogenesis of non-small cell lung cancer

被引:38
|
作者
Shijubo, N
Kojima, H
Nagata, M
Ohchi, T
Suzuki, A
Abe, S
Sato, N
机构
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
VEGF; bFGF; PD-ECGF; chemokine; MMP; VE-cadherin; integrin; osteopontin; mast cells;
D O I
10.1002/jemt.10257
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non-small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth factors and cytokines and influenced by proteolytic enzymes such as plasminogen activators and matrix metalloproteases, expression of adhesion molecules, and distribution of extracellular matrices. Fibroblasts, macrophages, mast cells, and endothelial cells themselves also affect angiogenesis. This review concentrates on angiogenic growth factors including vascular endothelial growth factor, angiopoietins, platelet derived endothelial growth factor, and basic fibroblast growth factor, proteases, adhesion molecules including vascular endothelial cadherin and integrins, osteopontin, and mast cell products in tumor angiogenesis of NSCLC. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:186 / 198
页数:13
相关论文
共 50 条
  • [31] Angiogenesis in non-small cell lung cancer - Microvessel area in needle biopsy in vascular tumor density
    Irion, Luciane C. Dreher
    Prolla, Joao Carlos
    Hartmann, Antonio A.
    Irion, Klaus L.
    Da Silva, Vinicius D.
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2008, 30 (02): : 83 - 91
  • [32] Testin is a tumor suppressor in non-small cell lung cancer
    Wang, Ming
    Wang, Qian
    Peng, Wen-Jia
    Hu, Jun-Feng
    Wang, Zu-Yi
    Liu, Hao
    Huang, Li-Nian
    ONCOLOGY REPORTS, 2017, 37 (02) : 1027 - 1035
  • [33] Tumor immunity landscape in non-small cell lung cancer
    Yu, Xiaoqing
    Wang, Xuefeng
    PEERJ, 2018, 6
  • [34] Non-Small Cell Lung Cancer-Tumor Biology
    Rojiani, Mumtaz V.
    Rojiani, Amyn M.
    CANCERS, 2024, 16 (04)
  • [35] Prognostic Value of Angiogenesis and Cell Adhesion Biomarkers in Non-small Cell Lung Cancer
    Syrigos, Kostas
    Soldatou, Kyriaki
    Grapsa, Dimitra
    Sfairopoulos, Dimitrios
    Charpidou, Andriani
    Trigidou, Rodoula
    Mitselou, Antigoni
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S833 - S833
  • [36] Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
    Rossi, A.
    Maione, P.
    Ferrara, M. L.
    Sacco, P. C.
    Schettino, C.
    Bareschino, M. A.
    Gridelli, C.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (30) : 3919 - 3930
  • [37] The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
    Arenberg, DA
    Polverini, PJ
    Kunkel, SL
    Shanafelt, A
    Hesselgesser, J
    Horuk, R
    Strieter, RM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (05) : 554 - 562
  • [38] Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
    Hall, Richard D.
    Le, Tri M.
    Haggstrom, Daniel E.
    Gentzler, Ryan D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 515 - 523
  • [39] The actual place of anti-angiogenesis in non-small cell lung cancer
    Mennecier, B.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S198 - S205
  • [40] MicroRNA-874 impedes angiogenesis in non-small cell lung cancer
    Chetty, Chandramu
    Maddirela, Dilip R.
    Gogineni, Venkateswara R.
    Chittivelu, Subramanyam
    Rao, Jasti S.
    Moorthy, Bhagavatula
    CANCER RESEARCH, 2014, 74 (19)